Revolution Medicines, Inc. (NASDAQ:RVMD) Q1 2024 Results Conference Call May 8, 2024 4:30 PM ET Company Participants Erin Graves - Senior Director, Corporate Communications and Investor Relations Dr. Mark Goldsmith - Chairman and Chief Executive Officer Jack Anders - Chief Financial Officer Dr. Steve Kelsey - President of R&D Dr. Wei Lin - Chief Medical Officer Conference Call Participants Marc Frahm - TD Cowen Michael Schmidt - Guggenheim Securities Eric Joseph - JPMorgan Jonathan Chang - Leerink Partners ...